{"id":"https://openalex.org/W7163687178","doi":"https://doi.org/10.1201/9781003730705-3","title":"In-silico Approaches for the Design of Kinase Inhibitors as Anticancer Agents","display_name":"In-silico Approaches for the Design of Kinase Inhibitors as Anticancer Agents","publication_year":2026,"publication_date":"2026-06-05","ids":{"openalex":"https://openalex.org/W7163687178","doi":"https://doi.org/10.1201/9781003730705-3"},"language":"en","primary_location":{"id":"doi:10.1201/9781003730705-3","doi":"https://doi.org/10.1201/9781003730705-3","is_oa":false,"landing_page_url":"https://doi.org/10.1201/9781003730705-3","pdf_url":null,"source":{"id":"https://openalex.org/S4306463075","display_name":"CRC Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320584","host_organization_name":"CRC Press","host_organization_lineage":["https://openalex.org/P4310320584","https://openalex.org/P4310320547"],"host_organization_lineage_names":["CRC Press","Taylor & Francis"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kinase Inhibitors","raw_type":"book-chapter"},"volume":{"id":"https://openalex.org/W7163686787","display_name":"Kinase Inhibitors"},"type":"book-chapter","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101637515","display_name":"M. Amin Mir","orcid":"https://orcid.org/0000-0003-4689-0507","observed_orcids":["https://orcid.org/0000-0003-4689-0507"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Amin Mir","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112880815","display_name":"Biswa Mohan Sahoo","orcid":"https://orcid.org/0000-0001-8822-0427","observed_orcids":["https://orcid.org/0000-0001-8822-0427"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Biswa Mohan Sahoo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5027706023","display_name":"Bimal Krishna Banik","orcid":"https://orcid.org/0000-0002-7873-9062","observed_orcids":["https://orcid.org/0000-0002-7873-9062"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bimal Krishna Banik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"39","last_page":"63"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9634000062942505,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9634000062942505,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13779","display_name":"Cancer Mechanisms and Therapy","score":0.01600000075995922,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.009100000374019146,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/kinase-inhibitors","display_name":"kinase inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/anticancer-agents","display_name":"anticancer agents","score":0.8820000290870667},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.8080000281333923},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7110000252723694},{"id":"https://openalex.org/keywords/allosteric-modulators","display_name":"allosteric modulators","score":0.8809999823570251},{"id":"https://openalex.org/keywords/dual-inhibitors","display_name":"dual inhibitors","score":0.9900000095367432},{"id":"https://openalex.org/keywords/precision-oncology","display_name":"precision oncology","score":0.7870000004768372},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.9409999847412109},{"id":"https://openalex.org/keywords/computer-aided-drug-discovery","display_name":"computational drug discovery","score":0.9309999942779541},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6140000224113464},{"id":"https://openalex.org/keywords/targeted-cancer-therapy","display_name":"targeted cancer therapy","score":0.6690000295639038}],"concepts":[{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5999000072479248},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5478000044822693},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.53329998254776},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4490000009536743},{"id":"https://openalex.org/C166342909","wikidata":"https://www.wikidata.org/wiki/Q845326","display_name":"Allosteric regulation","level":3,"score":0.4472000002861023},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.4368000030517578},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4325000047683716},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4309999942779541},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.3734999895095825},{"id":"https://openalex.org/C3018146709","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Anticancer drug","level":3,"score":0.36390000581741333},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.33180001378059387},{"id":"https://openalex.org/C2989108626","wikidata":"https://www.wikidata.org/wiki/Q904407","display_name":"Drug target","level":2,"score":0.2939000129699707},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.2921999990940094},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.28690001368522644},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.2797999978065491},{"id":"https://openalex.org/C2777210771","wikidata":"https://www.wikidata.org/wiki/Q4927124","display_name":"Block (permutation group theory)","level":2,"score":0.273499995470047},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.262800008058548},{"id":"https://openalex.org/C3020497934","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision oncology","level":3,"score":0.26080000400543213},{"id":"https://openalex.org/C2994543053","wikidata":"https://www.wikidata.org/wiki/Q7239206","display_name":"Preclinical testing","level":2,"score":0.2596000134944916},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.25450000166893005},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2526000142097473},{"id":"https://openalex.org/C3018449070","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signalling pathways","level":3,"score":0.2500999867916107}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1201/9781003730705-3","doi":"https://doi.org/10.1201/9781003730705-3","is_oa":false,"landing_page_url":"https://doi.org/10.1201/9781003730705-3","pdf_url":null,"source":{"id":"https://openalex.org/S4306463075","display_name":"CRC Press eBooks","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320584","host_organization_name":"CRC Press","host_organization_lineage":["https://openalex.org/P4310320584","https://openalex.org/P4310320547"],"host_organization_lineage_names":["CRC Press","Taylor & Francis"],"type":"ebook platform"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Kinase Inhibitors","raw_type":"book-chapter"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4412883404","https://openalex.org/W2060797544","https://openalex.org/W2077804275","https://openalex.org/W1966387612","https://openalex.org/W4410259379","https://openalex.org/W6968350781","https://openalex.org/W2997397781","https://openalex.org/W7155562836","https://openalex.org/W2002490984","https://openalex.org/W4397002223"],"abstract_inverted_index":{"The":[0,106],"rapid":[1],"advancement":[2],"of":[3,58,69,91,101,118],"precision":[4,131],"medicine":[5],"has":[6],"radically":[7],"altered":[8],"the":[9,59,70,92],"way":[10],"we":[11],"treat":[12],"cancer,":[13],"and":[14,36,47,56,83,94,113,129],"small-molecule":[15],"kinase":[16,60,104],"inhibitors":[17],"are":[18],"now":[19],"valuable":[20],"tools":[21],"in":[22],"targeted":[23],"therapies.":[24],"These":[25],"compounds":[26],"selectively":[27],"block":[28],"aberrant":[29],"signalling":[30],"pathways":[31],"that":[32],"support":[33],"tumor":[34],"initiation":[35],"progression.":[37],"This":[38],"chapter":[39],"highlights":[40],"new":[41],"scaffolds,":[42],"better":[43],"structure-activity":[44],"relationships":[45],"(SARs)":[46],"molecular":[48],"modification":[49],"strategies":[50],"aimed":[51],"at":[52],"optimizing":[53],"pharmacokinetics,":[54],"potency,":[55],"selectivity":[57],"inhibitor":[61],"class.":[62],"There":[63],"also":[64],"is":[65,88],"an":[66],"extensive":[67],"examination":[68],"principal":[71],"approaches":[72],"to":[73],"overcoming":[74],"drug":[75,121,124],"resistance,":[76],"including":[77,120],"synergistically":[78],"combining":[79],"pharmacotherapies,":[80],"allosteric":[81],"modulators,":[82],"dual-target":[84],"inhibitors.":[85,105],"Additionally,":[86],"there":[87],"a":[89],"summary":[90],"safety":[93],"efficacy":[95],"as":[96,98],"well":[97],"emerging":[99],"indications":[100],"FDA":[102],"approved":[103],"chapter's":[107],"final":[108],"commentary":[109],"examines":[110],"promising":[111],"preclinical":[112],"clinical":[114],"opportunities,":[115],"future":[116],"areas":[117],"investigation":[119],"repurposing,":[122],"computational":[123],"discovery":[125],"(including":[126],"drug-target":[127],"proteins)":[128],"next-generation":[130],"oncology":[132],"strategies.":[133]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-06-06T00:00:00"}